(Date:12/2/2009)...Newswire/ -- S*BIO Pte Ltd today announced data pr...18, at The American Society of Hematology 51st Ann...ata will be presented on the clinical results from...ling its safety, tolerability and pharmacokinetic/...ging from 100 to 600 mg. These doses were administ...
(Date:12/2/2009)...wire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ...maceutical company focused on endocrine therapy an... Drug Administration (FDA) has granted Fast Track ...ibitor compound, perifosine (KRX-0401), for the tr...eryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), i...
(Date:12/2/2009)...ewswire/ -- According to the National Institute of...gnosed with diabetes already have some stage of di...to the retina caused by leaky blood vessels, is a ...nd is one of the most feared diabetic complication...ve had diabetes for 10 years or more will experien...
(Date:12/1/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Chromium - Global Market Trends ,...-Global-Market-Trends.html ,, Worldwide demand... steel, while growth in aerospace and industrial g... chromium metal. Environmental constraints and rap...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9... Maxygen, Inc.,(Nasdaq: MAXY ), a biotechnology ...tein drugs, today announced that it will present a...d, Maxygen,s chief executive,officer, will present...lthcare Conference Monday, November 5, 9:30 a.m. ...ference Tuesday, November 6, 8:00 a.m. ET A live...
...p, Inc. (Nasdaq:,COWN) and Cowen Healthcare Royalt...t expansion of the CHRP team through the addition ...ined CHRP and rejoins founders Todd C. Davis,and C...n January of 2007 to,launch this initiative, as pr... continued to build and strengthen its,team throug...
...ominds Ltd., a,bio-diagnostics company specializin...anagement of autoimmune diseases and cancer, annou... Fox Chase Cancer Center (FCCC), an,NCI designated...test for,breast cancer. "We are very pleased to w...an, Glycominds, co-founder, CTO and VP R&D. "Glyco...
Other Biology Technology:Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 2Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 3Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests 2Sheep Growth Hormone from Cell Sciences
ELF® 97 Immunohistochemistry Kit from Molecular Probes (Invitrogen)
Mouse Anti-Human FACTOR I Monoclonal Antibody, Unconjugated, Clone 3R2/2 from AbD Serotec
GFX PCR DNA,Gel Band Purif,100 from GE Healthcare, formerly Amersham Biosciences
Biology Products: